Insuman Comb 15

Insulin human, the active ingredient in Insuman Comb 15, is an insulin presented as a 15% regular insulin / 85% NPH solution for injection for subcutaneous use. It treats diabetes mellitus in both type 1 and type 2 patients.

GNH USA supplies Insuman Comb 15 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Insuman Comb 15 is used to manage blood glucose in diabetes mellitus, a chronic metabolic disorder.

Type 1 diabetes mellitus: provides basal and prandial insulin coverage to maintain target glycaemic levels. Type 2 diabetes mellitus: assists in achieving glycaemic control when oral agents are insufficient, delivering both rapid and intermediate‑acting insulin. Insulin deficiency: supplies exogenous insulin to replace lacking endogenous insulin, supporting metabolic needs.

Common Side Effects: - Hypoglycaemia: low blood glucose levels, especially if meals are missed or dosing is excessive. - Injection site reactions: redness, swelling, or itching at the injection site. - Weight gain: increased caloric storage due to improved glucose utilization. - Lipodystrophy: localized fat accumulation or loss at repeated injection sites. - Edema: mild fluid retention, often in the lower extremities. - Nausea: occasional gastrointestinal discomfort.

Serious or Rare Side Effects: - Severe hypoglycaemia: can lead to seizures, loss of consciousness, or coma. - Anaphylactic reaction: rare but potentially life‑threatening allergic response. - Insulin antibodies: formation may alter insulin effectiveness. - Lipohypertrophy: pronounced fatty tissue buildup causing erratic insulin absorption. - Acute allergic dermatitis: widespread rash or hives. - Hypersensitivity bronchospasm: rare respiratory distress.

Insuman Comb 15 requires careful clinical oversight. - Dose titration: adjust based on regular blood glucose monitoring and physician guidance. - Hypoglycaemia risk: educate patients to recognize and treat low glucose promptly. - Renal impairment: use with caution; dose may need modification. - Pregnancy: consider only if benefits outweigh potential risks and under medical supervision. - Driving and operating machinery: avoid if experiencing hypoglycaemic symptoms. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Comb 15 may interact with several drug classes.

Major Interactions (Avoid): - Concurrent sulfonylureas: increased risk of severe hypoglycaemia. - Beta‑blockers: can mask typical hypoglycaemia warning signs. - MAO inhibitors: unpredictable alterations in glucose control.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may enhance insulin sensitivity; monitor glucose levels. - Thiazide diuretics: potential to raise blood glucose; watch for hyperglycaemia. - Corticosteroids: can increase insulin resistance; adjust dosage as needed.